Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin)

CardioVascular and Interventional Radiology

Volumn 35, Issue 2, 2012, Pages 399-405

  Watanabe, Shobu ^a   Nitta, Norihisa ^a   Ohta, Shinichi ^a   Sonoda, Akinaga ^a   Otani, Hideji ^a   Tomozawa, Yuki ^a   Nitta Seko, Ayumi ^a   Tsuchiya, Keiko ^a   Tanka, Toyohiko ^a   Takahashi, Masashi ^a   Murata, Kiyoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Arterial intervention; Chemoembolization; Embolization Embolotherapy; Experimental IR; Interventional oncology; Liver hepatic; Transarterial chemoembolization (TACE); Tumor Neoplasm

Indexed keywords

CISPLATIN; IODINATED POPPYSEED OIL; MIRIPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SCREENING; DRUG TISSUE LEVEL; GROWTH RATE; HUMAN; HUMAN CELL; LIVER TUMOR; NONHUMAN; POWDER; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMISTRY, PHARMACEUTICAL; CISPLATIN; ETHIODIZED OIL; HELA CELLS; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; ORGANOPLATINUM COMPOUNDS; POWDERS; RABBITS; RANDOM ALLOCATION; SUSPENSIONS; TUMOR CELLS, CULTURED;

EID: 84862862587     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0172-4     Document Type: Article

References (33)

1. Kinami Y, Miyazaki I (1978) The superselective and the selective one shot methods for treating inoperable cancer of the liver. Cancer 41: 1720-1727
2. Shibata J, Fujiyama S, Sato T, Kishimoto S et al. (1989) Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64: 1586-1594
3. Shimamura Y, Gunven P, Takenaka Y et al. (1988) Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer 61: 238-242
4. Ohnishi K, Sugita S, Nomura F et al. (1987) Arterial chemoembolization with mitomycin C microcapsules followed by transcatheter hepatic artery embolization for hepatocellular carcinoma. Am J Gastroenterol 82: 876-879
5. Okusaka T, Okuda S, Ueno H et al. (2002) Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma. Oncology 62: 228-233
6. Okita K (2006) Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 45 (5): 229-233
7. Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7 (3): 237-257
8. Achenbach T, Seifert JK, Pitton MB et al. (2002) Chemoembolization for primary liver cancer. Eur J Surg Oncol 28 (1): 37-41
9. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2): 429-442
10. Watban JA, Rodesch G, Alvarez H et al. (1995) Transarterial embolization of vein of Galen aneurysmal malformation after unsuccessful stereotactic radiosurgery. Report of three cases. Childs Nerv Syst 11 (7): 406-408
11. Hyare H, Desigan S, Brookes JA, Guiney MJ et al. (2007) Endovascular management of major arterial hemorrhage as a complication of inflammatory pancreatic disease. J Vasc Interv Radiol 18 (5): 591-596
12. Ono Y, Yoshimasu T, Ashikaga R et al. (2000) Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol 23: 564-568
13. Venook AP, Stagg RJ, Lewis BJ et al. (1990) Chemoembolization for hepatocellular carcinoma. J Clin Oncol 8: 1108-1114
14. Kawakami A, Yoshioka H, Ohkusa Okafuji T et al. (1993) Effects of intrahepatic arterial injection of cisplatin suspended lipiodol on hepatocellular carcinoma. J Jpn Soc Cancer Ther 28: 794-803
15. Malagari K, Chatzimichael K, Alexopoulou E et al. (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31 (2): 269-280
16. Varela M, Real MI, Burrel M et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics. J Hepatol 46 (3): 474-481
17. Yoshikawa M, Ono N, Yodono H et al. (2008) Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res 38: 474-483
18. Kishimoto S, Miyazawa K, Terakawa Y et al. (2000) Cytotoxicity of cis-[ ( (1R, 2R)-1,2-Cyclohexanediamine-N,N0) bis (myristato)]- platinum (II) suspended in lipiodol in a newly established cisplatin resistant rat hepatoma cell line. Jpn J Cancer Res 91: 1326-1332
19. Kishimoto S, Noguchi T, Yamaoka T et al. (2000) In vitro cytotoxicity of cis[ ( (1R, 2R)-1,2-cyclohexanediamine-N,N0)bis (myristato)] platinum (II) suspended in lipiodol in rat hepatoma AH-109A cells and human tumor cell lines. Biol Pharm Bull 23 (4): 487-491
20. Wang Z, Zhou J, Fan J et al. (2009) Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opin Investig Drugs 18 (11): 1595-1604
21. Rathore R, Safran H, Soares G et al. (2010) Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a Brown University oncology group study. Am J Clin Oncol 33 (1): 43-46
22. Uhm JE, Park JO, Lee J et al. (2009) A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma. Cancer Chemother Pharmacol 63 (5): 929-935
23. Haaga JR, Exner AA, Wang Y et al. (2005) Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits. Radiology 237 (3): 911-918
24. Wright KC, Yang P, Van Pelt CS et al. (2005) Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors. J Exp Ther Oncol 5 (1): 55-68
25. Maeda S, Fujiyama S, Tanaka M et al. (2002) Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization. Hepatol Res 23 (3): 202-210
26. Rosenberg B, Van Camp L, Krigas T (1964) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205: 698-699
27. Zhang J, Liu D, Li Y et al. (2009) Status of non-classical mononuclear platinum anticancer drug development. Mini Rev Med Chem 9 (11): 1357-1366
28. Luo FR, Yen TY, Wyrck SD et al. (1999) High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin. J Chromatogr B 724: 345-356
29. Kishimoto S, Noguchi T, Yamaoka T et al. (2000) In vitro release of SM-11355, cis[ ( (1R, 2R)-1,2-cyclohexanediamine-N,N0)bis (myristato)] platinum (II) suspended in lipiodol. Biol Pharm Bull 23 (5): 637-640
30. Yamashita Y, Taketomi A, Itoh S et al. (2010) Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call-) in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 65: 301-307
31. Hanada M, Baba A, Tsutsumishita Y et al. (2009) Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats. Cancer Sci 100 (1): 189-194
32. Hanada M, Baba A, Tsutsumishita Y et al. (2009) Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis. Cancer Chemother Pharmacol 64 (3): 473-483
33. Yamamoto K, Shimizu T, Narabayashi I (2000) Intra-arterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma. Cardiovasc Interv Radiol 23: 26-39